In this regard, the present study seeks to assess the diagnostic performance of the ExoDx IntelliScore and OPKO4K score in predicting prostate cancer diagnosis in men presenting with elevated PSA—both as independent predictors and in combination with clinical/MRI characteristics. The gene discussed is KLK3; the disease is prostate carcinoma.